List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 700 studies with search of:   "Rituximab"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting Multi-Center Trial of Revlimid® and Rituximab, for First-Line Treatment of Chronic Lymphocytic Leukemia (CLL)
Conditions: Chronic Lymphocytic Leukemia;   CLL;   Untreated;   Front-Line;   First-Line;   Initial Therapy
Interventions: Drug: Lenalidomide and Rituximab;   Drug: Lenalidomide and Rituximab
2 Active, not recruiting A Pilot Trial of Rituxan in Refractory Myasthenia Gravis
Condition: Refractory Myasthenia Gravis
Intervention: Drug: Rituximab (Rituxan)
3 Recruiting Combination Therapy Using Lenalidomide (Revlimid)- Low Dose Dexamethasone and Rituximab for Treatment of Rituximab-Resistant, Non-Aggressive B-Cell Lymphomas
Conditions: Follicular Lymphoma;   Marginal Zone B-Cell Lymphoma;   MALT Lymphoma;   Lymphoma of Mucosa-Associated Lymphoid Tissue;   Lymphoma, Small Lymphocytic;   Waldenstrom Macroglobulinemia;   Mantle-Cell Lymphoma
Intervention: Drug: lenalidomide-low dose dexamethasone plus rituximab
4 Recruiting The Effect of Rituximab on the Development of Anti-Donor Antibodies
Condition: Renal Transplant Rejection
Interventions: Drug: Rituximab;   Drug: No Rituximab
5 Active, not recruiting SCORE Study: A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis and Inadequate Response to Methotrexate.
Condition: Rheumatoid Arthritis
Interventions: Drug: rituximab [MabThera/Rituxan];   Drug: rituximab [MabThera/Rituxan];   Drug: Placebo;   Drug: Methotrexate
6 Recruiting A Study of Galiximab + Rituximab Versus Rituximab + Placebo in Follicular Non-Hodgkin's Lymphoma (NHL)
Condition: Lymphoma, Non-Hodgkin's
Interventions: Drug: Galiximab in combination with rituximab;   Drug: Rituximab in combination with placebo
7 Terminated Fludarabine, Pixantrone and Rituximab vs Fludarabine and Rituximab forRelapsed or Refractory Indolent NHL
Condition: Non-Hodgkin's Lymphoma
Interventions: Drug: fludarabine and rituximab;   Drug: fludarabine, rituximab, pixantrone
8 Recruiting Zevalin® First Line in Follicular Lymphoma
Condition: Follicular Lymphoma
Interventions: Drug: 90Yttrium-Ibritumomab Tiuxetan (Zevalin®)+Rituximab;   Drug: Rituximab
9 Not yet recruiting A Study of Maintenance Treatment With MabThera (Rituximab) in Patients With Progressive B-Cell Chronic Lymphocytic Leukemia
Condition: Lymphocytic Leukemia, Chronic
Interventions: Drug: rituximab [MabThera/Rituxan];   Drug: rituximab [MabThera/Rituxan];   Drug: cladribine;   Drug: cyclophosphamide;   Drug: rituximab [MabThera/Rituxan]
10 Active, not recruiting Fludarabine, Mitoxantrone, and Dexamethasone (FND) Plus Rituximab for Lymphoma Patients
Condition: Lymphoma
Interventions: Drug: Fludarabine;   Drug: Novantrone;   Drug: Decadron;   Drug: Rituximab;   Drug: Interferon;   Drug: Doxorubicin;   Drug: Vincristine;   Drug: Bleomycin;   Drug: Cyclophosphamide;   Drug: Etoposide;   Drug: Cisplatin;   Drug: Ara-C;   Drug: Methyl-Prednisolone;   Drug: Procarbazine;   Drug: Prednisone
11 Active, not recruiting A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Had an Inadequate Response to a TNF-Blocker.
Condition: Rheumatoid Arthritis
Interventions: Drug: rituximab [MabThera/Rituxan];   Drug: Methotrexate
12 Recruiting R-ICE (ICE Plus Rituximab) Versus R-DHAP (DHAP Plus Rituximab) in Patients Aged 18-65 With Relapse Diffuse Large B-Cell Lymphoma
Condition: Lymphoma, Large-Cell, Diffuse
Interventions: Drug: DHAP plus rituximab;   Drug: ICE plus rituximab
13 Active, not recruiting A Study of Retreatment With MabThera (Rituximab) in Combination With Methotrexate in Patients With Rheumatoid Arthritis (RA)
Condition: Rheumatoid Arthritis
Interventions: Drug: rituximab [MabThera/Rituxan];   Drug: rituximab [MabThera/Rituxan];   Drug: rituximab [MabThera/Rituxan]
14 Recruiting Effect of B-Cell Depletion in Patients With Primary Sjögren's Syndrome
Conditions: Primary Sjögren's Syndrome;   Xerostomia;   Hyposalivation;   Keratoconjunctivitis Sicca;   Fatigue
Interventions: Drug: MabThera (rituximab);   Drug: Rituximab, Mabthera
15 Recruiting Comparison Study of Rituximab Plus Sargramostim to Rituximab Alone for Relapsed Follicular B-Cell Lymphoma, a Form of Non-Hodgkin's Lymphoma
Condition: Lymphoma, Follicular
Interventions: Drug: Rituximab + Sargramostim (Leukine, BAY86-5326);   Drug: Rituximab
16 Recruiting Rituximab-HCVAD in Patients With B-Cell Non-Hodgkin's Lymphoma
Condition: Lymphoma
Interventions: Drug: Rituximab;   Drug: Cyclophosphamide;   Drug: Doxorubicin;   Drug: Vincristine;   Drug: Dexamethasone;   Drug: Methotrexate;   Drug: Cytarabine;   Drug: Prednisone
17 Active, not recruiting Rituximab+Standard CHOP vs Rituximab+bi-Weekly CHOP for Untreated Stage III/IV Low-Grade B-Cell Lymphoma (JCOG0203)
Condition: Lymphoma, B-Cell
Interventions: Drug: Rituximab + Standard CHOP;   Drug: Rituximab + Bi-weekly CHOP
18 Recruiting Study of the Influence of Plasma Exchange on the Pharmacokinetics of Rituximab
Conditions: Humoral Acute Refection of Renal Transplant;   Autoimmune Diseases
Interventions: Drug: Rituximab 375;   Drug: rituximab 1000
19 Recruiting Alemtuzumab + Rituximab Consolidation in CLL
Conditions: Chronic Lymphocytic Leukemia;   Leukemia
Interventions: Drug: Rituximab;   Drug: Alemtuzumab
20 Recruiting Study of the Combination of Rituximab, Cyclophosphamide, Doxorubicin, VELCADE, and Prednisone or Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With Newly Diagnosed Mantle Cell Lymphoma
Condition: Mantle Cell Lymphoma
Interventions: Drug: Rituximab, Cyclophosphamide, Doxorubicin, VELCADE, and Prednisone;   Drug: Rituximab, Cyclophosphamide, Doxorubicin, Vincristine and Prednisone

Previous Page Studies Shown (1-20) Next (21-40)
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services